Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
compliance
Pharma
Novo, Alvotech written up after FDA site inspections
From Indiana to Iceland, the FDA disclosed concerns raised during recent visits to a pair of manufacturing sites with troubled regulatory histories.
Fraiser Kansteiner
Jul 17, 2026 10:56am
FDA unveils 1-day assessment pilot to complement inspections
May 6, 2026 3:08pm
FDA clarifies Form 483 expectations after production inspections
May 1, 2026 10:52am
Supply chain group Qualifyze raises $12M in funding round
Aug 22, 2023 9:40am
Federal Court bans Florida compounder until FDA regulations are
Sep 20, 2021 3:10pm
Novartis corrects chairman's doctor kickback comments
Mar 25, 2021 10:01am
